You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Claims for Patent: 9,579,421


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,579,421
Title:Bone grafts and methods of making and using bone grafts
Abstract: Provided herein are bone grafts and methods of making and using the same, as well as products and kits that include such bone grafts. In particular, bone grafts are provided that include osteogenic stem cells in a mix of osteoinductive demineralized bone matrix and osteoconductive cortico-cancellous chips.
Inventor(s): Bhat; Archana (Royersford, PA), Laskowitz; Dan (Lancaster, PA), Joe; Patrick (Royersford, PA), Adams; Mark (Downingtown, PA), Boyer, II; Michael Lee (Phoenixville, PA)
Assignee: Globus Medical Inc. (Audubon, PA)
Application Number:14/175,184
Patent Claims:1. A method of making a bone graft, the method comprising: (A) obtaining and preparing demineralized cortical fibers by separating cortical bone from bone marrow, rinsing and milling the cortical bone to fibers, demineralizing the cortical fibers, rinsing the cortical fibers in water, and treating the cortical fibers to adjust the pH of the water the fibers are in to between 6.5 and 7 to form the demineralized cortical fibers; (B) obtaining cancellous bone chips from fresh frozen condyles by milling condyles using a bone mill to produce the cancellous bone chips having a size in the range of 0.05 to 1.5 mm and treating by a method selected from the group consisting of: (1) treating the cancellous chips with 0.3-0.5% saline, rinsing the saline treated chips with phosphate buffered saline, mixing the chips with freezing media and dimethyl sulfoxide (DMSO), and freezing the chips in media and storing the chips to form cell enriched cancellous chips; (2) treating the cancellous chips with 0.3-0.5% saline, and rinsing the saline treated chips with phosphate buffered saline; culturing the chips in medium, for up to 10 days; and after the culture period mixing the chips with freezing media and freezing the chips in media and storing the chips to form cell enriched cancellous chips; (3) treating the cancellous chips with collagenase in an incubator for 1-3 hours at 37.degree. C. and 5% O.sub.2 with periodic agitation, forming a supernatant; filtering the supernatant through a filter; centrifuging the filtered cell suspension for 5-15 minutes forming a cell pellet; reconstituting the cell pellet in cell culture media and plating in a tissue culture flask; culturing the cells for up to 10 days; detaching the cells using a dissociation agent and reseeding on the cancellous chips to form cell enriched cancellous chips; mixing the cell enriched cancellous chips with freezing media and storing the chips; and (4) treating the cancellous chips with 0.3-0.5% saline, and then treating and processing the saline treated chips as in (3) to form cell enriched cancellous chips; and (C) mixing the demineralized cortical fibers and cell enriched cancellous chips at a ratio of about 1:1 to 2:1; thereby providing a bone graft material that is osteogenic, osteoinductive and osteoconductive.

2. The method of claim 1, wherein the cell enriched cancellous chips are stored at a temperature between -80.degree. C. and -180.degree. C.

3. The method of claim 1, wherein the concentration of osteogenic cells in the bone graft is more than 20,000 cells/cc of final product.

4. The method of claim 1, wherein the cortical fibers are milled to a length to width ratio of 5:1 to 500:1.

5. The method of claim 1, wherein the cortical fibers are freeze dried and stored at room temperature.

6. The method of claim 1, wherein the cancellous bone chips are obtained from fresh frozen condyles of long bones.

7. The method of claim 1, wherein the cortical fibers have a size in the range of 250 microns to 3 mm.

8. The method of claim 1, wherein the bone graft material is in the form of a putty.

9. A method of making a bone graft comprising: (A) obtaining and preparing demineralized cortical fibers by separating cortical bone from bone marrow, rinsing and milling the cortical bone to fibers, demineralizing the cortical fibers, rinsing the cortical fibers in water, and treating the cortical fibers to adjust the pH of the water the fibers are in to between 6.5 and 7 to form the demineralized cortical fibers; (B) obtaining cancellous bone chips from fresh frozen condyles by milling condyles using a bone mill to produce the cancellous chips having a size in the range of 0.05-1.5 mm and treating by a method selected from the group consisting of: (1) treating the cancellous chips with 0.3-0.5% saline, rinsing the saline treated chips with phosphate buffered saline, mixing the chips with freezing media and dimethyl sulfoxide (DMSO), and freezing the chips in media and storing the chips to form cell enriched cancellous chips; (2) treating the cancellous chips with 0.3-0.5% saline, and rinsing the saline treated chips with phosphate buffered saline; culturing the chips in medium, for up to 10 days; and after the culture period mixing the chips with freezing media and freezing the chips in media and storing the chips to form cell enriched cancellous chips; (3) treating the cancellous chips with collagenase in an incubator for 1-3 hours at 37.degree. C. and 5% O.sub.2 with periodic agitation, forming a supernatant; filtering the supernatant through a filter; centrifuging the filtered cell suspension for 5-15 minutes forming a cell pellet; reconstituting the cell pellet in cell culture media and plating in a tissue culture flask; culturing the cells for up to 10 days; detaching the cells using a dissociation agent and reseeding on the cancellous chips to form cell enriched cancellous chips; mixing the cell enriched cancellous chips with freezing media and storing the chips; and (4) treating the cancellous chips with 0.3-0.5% saline, and then treating and processing the chips as in (3) to form cell enriched cancellous chips; and (C) mixing the demineralized cortical fibers and cell enriched cancellous chips at a ratio of about 1:1 to 2:1; thereby providing a bone graft material that includes osteogenic stem cells in a mix of osteoinductive demineralized cortical bone and osteoconductive cancellous chips.

10. The method of claim 9, wherein the concentration of the osteogenic stem cells in the bone graft is more than 20,000 cells/cc.

11. The method of claim 9, wherein the hone graft material is stored at a temperature between -80.degree. C. and -180.degree. C.

12. The method of claim 9, wherein the cortical fibers are milled to a length to width ratio of 5:1 to 500:1.

13. The method of claim 9, wherein the cortical fibers are freeze dried and stored at room temperature.

14. The method of claim 9, wherein the cortical fibers have a size in the range of 250 microns to 3 mm.

15. The method of claim 9, wherein the bone graft material is in the form of a putty.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.